| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC1104 |
| Trial ID | ISRCTN19144142 |
| Disease | B-Cell Lymphoblastic Leukemia | T-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GC027 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Investigating the safety and efficacy of a Universal CAR-T cell immunotherapy in patients with relapse and refractory T-cell acute lymphoblastic leukemia and T lymphoblastic lymphoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Gracell Biotechnologies Co., Ltd |
| Cohort 1 | |||||||||
|
|||||||||